Theralase® Awarded TSX Venture 50™ Recognition as a Top Performing Company
February 21, 2023 07:35 ET
|
Theralase Technologies Inc.
TORONTO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research...
Emerald Health Therapeutics Named as #1 2018 TSX Venture 50™ Performer
February 22, 2018 08:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V:EMH) (OTCQX:EMHTF) ("Emerald") has achieved the #1 ranking in the 2018 TSX Venture 50™ for the...